Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • Log out
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • Log out
  • My Cart
Journal of Nuclear Medicine

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • View or Listen to JNM Podcast
  • Visit JNM on Facebook
  • Join JNM on LinkedIn
  • Follow JNM on Twitter
  • Subscribe to our RSS feeds
Meeting ReportMolecular Targeting Technologies - Radioactive and Nonradioactive Probes: Radiopharmacy

Fast and facile purification of 68Ga-labeled compounds using solid-phase extraction

Maarten Brom, Gerben Franssen, Lieke Joosten, Wim Oyen, Martin Gotthardt and Otto Boerman
Journal of Nuclear Medicine May 2011, 52 (supplement 1) 462;
Maarten Brom
1Department of Nuclear Medicine, Radboud University Nijmegen Medical Centre, Nijmegen, Netherlands
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Gerben Franssen
1Department of Nuclear Medicine, Radboud University Nijmegen Medical Centre, Nijmegen, Netherlands
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Lieke Joosten
1Department of Nuclear Medicine, Radboud University Nijmegen Medical Centre, Nijmegen, Netherlands
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Wim Oyen
1Department of Nuclear Medicine, Radboud University Nijmegen Medical Centre, Nijmegen, Netherlands
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Martin Gotthardt
1Department of Nuclear Medicine, Radboud University Nijmegen Medical Centre, Nijmegen, Netherlands
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Otto Boerman
1Department of Nuclear Medicine, Radboud University Nijmegen Medical Centre, Nijmegen, Netherlands
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Info & Metrics
Loading

Abstract

462

Objectives Chelate-conjugated compounds can be labeled with 68Ga in a one-step procedure. During the labeling procedure formation of 68Ga-colloid may occur. Upon i.v. injection 68Ga colloid will accumulate in the liver and spleen. Here, we compared various methods to remove 68Ga colloid from a 68Ga-labeled tracer preparation.

Methods DOTA-Exendin-3 was labeled with 68Ga and quality control was performed with ITLC-SG with two mobile phases to determine the content of unincorporated 68Ga and 68Ga colloid. The labeled compound was purified by (1) gel filtration (GF), (2) RP-HPLC on a C18 column or (3) solid-phase extraction (SPE) on a HLB cartridge (Waters). The in vivo characteristics were determined in BALB/c nude mice and PET images were acquired 1 h p.i. Unpurified 68Ga-Exendin and 111In-labeled Exendin-3 were used as a reference.

Results The colloid content of 111In-Exendin-3 and unpurified, GF, RP-HPLC and SPE-purified 68Ga-Exendin-3 was < 3%, 9%, 7% < 3% and < 3%, respectively. Unpurified Exendin-3 showed high liver and spleen uptake: 6.1 ± 1.0 and 4.5 ± 0.7 %ID, respectively. GF partly removed 68Ga colloid, resulting in moderate liver and spleen uptake (3.0 ± 0.3 and 1.4 ± 0.3 %ID/g). SPE-purified Exendin-3 showed very low liver (0.8 ± 0.0 %ID/g) and spleen (0.5 ± 0.1 %ID/g) uptake and were similar to that of RP-HPLC purified Exendin-3 (0.6 ± 0.1 and 0.4 ± 0.1 %ID/g, respectively). SPE and RP-HPLC showed the same liver and spleen uptake as 111In-Exendin-3: 0.7 ± 0.1 and 0.3 ± 0.1 %ID/g, respectively. The PET images clearly showed the enhanced liver uptake after injection of unpurifed 68Ga-Exendin-3. Liver uptake of GF purified Exendin-3 was reduced, whereas it was absent in the PET images after injection of the HPLC and SPE-purified preparations (Figure 1).

Conclusions Solid-phase extraction using HLB is a fast and simple method to remove 68Ga-colloid. The uptake in liver and spleen of the SPE-purified product was similar to 111In-Exendin-3 or HPLC purified 68Ga-Exendin-3, indicating complete removal of 68Ga-colloid

Back to top

In this issue

Journal of Nuclear Medicine
Vol. 52, Issue supplement 1
May 2011
  • Table of Contents
  • Index by author
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Journal of Nuclear Medicine.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Fast and facile purification of 68Ga-labeled compounds using solid-phase extraction
(Your Name) has sent you a message from Journal of Nuclear Medicine
(Your Name) thought you would like to see the Journal of Nuclear Medicine web site.
Citation Tools
Fast and facile purification of 68Ga-labeled compounds using solid-phase extraction
Maarten Brom, Gerben Franssen, Lieke Joosten, Wim Oyen, Martin Gotthardt, Otto Boerman
Journal of Nuclear Medicine May 2011, 52 (supplement 1) 462;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Fast and facile purification of 68Ga-labeled compounds using solid-phase extraction
Maarten Brom, Gerben Franssen, Lieke Joosten, Wim Oyen, Martin Gotthardt, Otto Boerman
Journal of Nuclear Medicine May 2011, 52 (supplement 1) 462;
Twitter logo Facebook logo LinkedIn logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One
Bookmark this article

Jump to section

  • Article
  • Info & Metrics

Related Articles

  • No related articles found.
  • Google Scholar

Cited By...

  • No citing articles found.
  • Google Scholar

More in this TOC Section

Molecular Targeting Technologies - Radioactive and Nonradioactive Probes: Radiopharmacy

  • Simple automated radiosynthesis of 10-[11C]methoxy-20(S)-camptothecin and biodistribution in normal mice
  • Potential evaluation of 111In-Hexa lactoside as a novel functional liver imaging agent
  • Modified technique for manual synthesis of 68Ga-Citrate with high radiochemical purity
Show more Molecular Targeting Technologies - Radioactive and Nonradioactive Probes: Radiopharmacy

Radiopharmacy II - Radiopharmaceutical Synthesis Optimization and Quality Control

  • Simple automated radiosynthesis of 10-[11C]methoxy-20(S)-camptothecin and biodistribution in normal mice
  • Potential evaluation of 111In-Hexa lactoside as a novel functional liver imaging agent
  • Modified technique for manual synthesis of 68Ga-Citrate with high radiochemical purity
Show more Radiopharmacy II - Radiopharmaceutical Synthesis Optimization and Quality Control

Similar Articles

SNMMI

© 2025 SNMMI

Powered by HighWire